1. Home
  2. FUTU vs HOLX Comparison

FUTU vs HOLX Comparison

Compare FUTU & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUTU
  • HOLX
  • Stock Information
  • Founded
  • FUTU 2011
  • HOLX 1985
  • Country
  • FUTU Hong Kong
  • HOLX United States
  • Employees
  • FUTU N/A
  • HOLX N/A
  • Industry
  • FUTU Investment Bankers/Brokers/Service
  • HOLX Medical Electronics
  • Sector
  • FUTU Finance
  • HOLX Health Care
  • Exchange
  • FUTU Nasdaq
  • HOLX Nasdaq
  • Market Cap
  • FUTU N/A
  • HOLX 16.3B
  • IPO Year
  • FUTU 2019
  • HOLX 1990
  • Fundamental
  • Price
  • FUTU $103.62
  • HOLX $61.32
  • Analyst Decision
  • FUTU Strong Buy
  • HOLX Buy
  • Analyst Count
  • FUTU 5
  • HOLX 14
  • Target Price
  • FUTU $111.20
  • HOLX $84.17
  • AVG Volume (30 Days)
  • FUTU 2.7M
  • HOLX 2.6M
  • Earning Date
  • FUTU 03-13-2025
  • HOLX 05-01-2025
  • Dividend Yield
  • FUTU 1.88%
  • HOLX N/A
  • EPS Growth
  • FUTU 27.23
  • HOLX 50.83
  • EPS
  • FUTU 5.01
  • HOLX 3.16
  • Revenue
  • FUTU $1,541,380,749.00
  • HOLX $4,039,000,000.00
  • Revenue This Year
  • FUTU $25.16
  • HOLX $3.42
  • Revenue Next Year
  • FUTU $13.05
  • HOLX $5.16
  • P/E Ratio
  • FUTU $21.91
  • HOLX $19.44
  • Revenue Growth
  • FUTU 31.60
  • HOLX 1.76
  • 52 Week Low
  • FUTU $51.80
  • HOLX $60.34
  • 52 Week High
  • FUTU $130.88
  • HOLX $84.67
  • Technical
  • Relative Strength Index (RSI)
  • FUTU 44.09
  • HOLX 42.16
  • Support Level
  • FUTU $105.81
  • HOLX $60.36
  • Resistance Level
  • FUTU $114.50
  • HOLX $62.57
  • Average True Range (ATR)
  • FUTU 5.57
  • HOLX 1.38
  • MACD
  • FUTU -1.27
  • HOLX 0.23
  • Stochastic Oscillator
  • FUTU 6.81
  • HOLX 18.56

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: